This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. shed 3.4% to $161.35 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50.
This was the stock's second consecutive day of losses.
Charles River Laboratories International Inc. closed 41.0% short of its 52-week high of $273.32, which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors, as Labcorp Holdings Inc. fell 0.8% to $234.45, Alnylam Pharmaceuticals Inc. fell 3.4% to $280.96, and Bio-Techne Corp. fell 1.78% to $59.98.
Trading volume totaled 909,362, compared to the 50-day average of 1.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 25, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。